<DOC>
	<DOCNO>NCT00112697</DOCNO>
	<brief_summary>RATIONALE : Radiation therapy use high-energy x-ray kill tumor cell . Drugs use chemotherapy , docetaxel , fluorouracil , cisplatin , work different way stop growth tumor cell , either kill cell stop divide . Giving radiation therapy together chemotherapy may kill tumor cell . It yet know whether radiation therapy , docetaxel , fluorouracil effective radiation therapy , docetaxel , cisplatin first-line therapy treat pancreatic cancer . PURPOSE : This randomized phase II trial study radiation therapy , docetaxel , fluorouracil see well work first-line therapy compare radiation therapy , docetaxel , cisplatin treat patient metastatic pancreatic cancer remove surgery .</brief_summary>
	<brief_title>Radiation Therapy Docetaxel With Either Fluorouracil Cisplatin First-Line Therapy Treating Patients With Metastatic Pancreatic Cancer That Can Be Removed By Surgery</brief_title>
	<detailed_description>OBJECTIVES : Primary - Compare 6-month progression-free survival rate patient unresectable metastatic adenocarcinoma pancreas treat radiotherapy docetaxel combination either fluorouracil cisplatin first-line therapy . Secondary - Compare toxicity regimens patient . - Compare objective response rate patient treat regimen . - Compare overall survival patient treat regimen . OUTLINE : This randomize , multicenter study . Patients randomize 1 2 treatment arm . - Arm I : Patients undergo radiotherapy celiac area daily 5 day week 6 week . Patients also receive docetaxel IV weekly fluorouracil IV daily 6 week . - Arm II : Patients undergo radiotherapy receive docetaxel arm I . Patients also receive cisplatin IV weekly 6 week . In arm , patient experience disease progression completion chemoradiotherapy may receive additional course chemotherapy . PROJECTED ACCRUAL : A total 80 patient ( 40 per treatment arm ) accrue study within 3 year .</detailed_description>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically cytologically confirm adenocarcinoma pancreas No pancreatic tumor type , include either follow : Neuroendocrine tumor Ampulla Vater carcinoma Metastatic disease Measurable evaluable disease Unresectable disease , define either follow : Failed prior attempt surgical resection laparotomy Surgical resection contraindicate radiographic criterion ( e.g. , arterial vascular invasion ) No cerebral metastasis PATIENT CHARACTERISTICS : Age 18 75 Performance status Karnofsky 70100 % Life expectancy Not specify Hematopoietic Absolute neutrophil count ≥ 1,500/mm^3 Platelet count ≥ 100,000/mm^3 Hepatic Bilirubin &lt; 1.5 time upper limit normal No hepatic disturbance Renal Creatinine &lt; 120 mmol/L Cardiovascular No untreated cardiac coronary insufficiency No uncontrolled symptomatic arrhythmia No uncontrolled angina Pulmonary No uncontrolled respiratory insufficiency Other Not pregnant nursing Fertile patient must use effective contraception No malignancy except basal cell skin cancer carcinoma situ cervix No peripheral neuropathy ≥ grade 2 No ongoing active infection No serious uncontrolled medical disorder would preclude study treatment PRIOR CONCURRENT THERAPY : Biologic therapy Not specify Chemotherapy No prior chemotherapy Endocrine therapy Not specify Radiotherapy No prior radiotherapy celiac pancreatic area Surgery See Disease Characteristics</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2006</verification_date>
	<keyword>adenocarcinoma pancreas</keyword>
	<keyword>stage IV pancreatic cancer</keyword>
</DOC>